Heteroaryl imidazolone derivatives as JAK inhibitors
The present invention relates to a compound of formula (I), to the process for preparing such compounds and to their use in the treatment of a pathological condition or disease susceptible to amelioration by sphingosine-1-phosphate receptors (S1P1) agonists.
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
16.01.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!